<DOC>
	<DOCNO>NCT02970032</DOCNO>
	<brief_summary>The purpose study determine fix dose heparin infusion rate 500 units/hour sufficient maintain target anti-Xa 0.1-0.35 IU/mL VTE prophylaxis patient undergo microvascular surgery . Additionally , pilot protocol develop titrate heparin infusion ensure patient sufficient VTE prophylaxis . All patient enrol observational arm study receive anti-Xa level monitoring . Patients out-of-range anti-Xa level cross interventional arm study receive real time heparin infusion dose adjustment per pilot protocol . The primary outcome measure percentage patient anti-Xa level target range 0.1-0.35 IU/mL heparin infusion 500 units/hour .</brief_summary>
	<brief_title>Evaluation Anti-Xa Levels Surgery Patients Receiving Fixed Dose Heparin</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Patients undergo surgical procedure Initiation heparin infusion rate 500 units/hour intraoperatively postoperatively Age &lt; 18 year old Pregnant Incarcerated Mentally disable</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>